Catalyst Wire Dossier Catalyst Wire Dossier

TFV 1% Gel

tenofovir disoproxil fumarate gel
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TFV 1% Gel, covering 2016-02-10 to 2016-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women [Phase 2]

See pricing